Atlas Trials

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

Clinical trial NCT03109379 · COMPLETED

Trial details

NCT number
NCT03109379
Sponsor
Taris Biomedical LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Idiopathic Overactive Bladder With Urinary Incontinence
Start date
2017-04-04
Primary completion
2019-09-27
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.